COMMUNIQUÉS West-GlobeNewswire

Cannabis Wheaton Income Corp. Announces New Joint Venture with Peter Quiring - One of Canada’s Largest Greenhouse Builders and Operators to Develop 1.4 Million Square Foot Purpose Built Greenhouse for Cannabis Cultivation

16/02/2018 - 13:30

VANCOUVER, British Columbia, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or "Wheaton" or the " Company ") is pleased to announce that it has [...]

Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call and Webcast on February 22, 2018

16/02/2018 - 13:00

THE WOODLANDS, Texas, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), will release its fourth quarter and full-year 2017 financial results on Thursday, February 22, 2018 before market [...]

Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros™

16/02/2018 - 13:00

SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U.S. Food and Drug [...]

RSNA17 AI Bone Age Challenge Champion, 16 Bit, Offers Award-Winning Algorithm on EnvoyAI Platform Free for Research Use

16/02/2018 - 12:30

CAMBRIDGE, Mass., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Artificial intelligence platform provider EnvoyAI ( www.envoyai.com ) today announced a new partnership with 16 Bit ( www.16bit.ai ), the winner of the Radiological [...]

Notice of Nexstim Plc 2017 Full Year Results

16/02/2018 - 08:01

Company announcement, Helsinki, 16 February 2018, at 9 am Notice of Nexstim Plc 2017 Full Year Results Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company developing and marketing [...]

Immunicum AB (publ) Year-End Report (October - December 2017) Corporate Update and Outlook

16/02/2018 - 08:00

Press Release 16 February 2018 Immunicum AB (publ) Year-End Report (October - December 2017) Corporate Update and Outlook Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer [...]

Photocure Announces U.S. FDA Approval of New Indications for Blue Light Cystoscopy with Cysview®

16/02/2018 - 07:55

Oslo, Norway, February 16, 2018 Photocure ASA (OSE: PHO), announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Light [...]

ESPERITE (ESP): EUR 500,000 of new funding provided by European Select Growth Opportunities Fund until March 2, 2018.

16/02/2018 - 07:18

Continuation of support to Esperite's strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines Amsterdam, The Netherlands - 16 February 2018 As of [...]

ABLYNX ANNOUNCES OPTION EXERCISE BY SANOFI FOR TWO ADDITIONAL MULTI-SPECIFIC NANOBODY PRODUCT CANDIDATES

16/02/2018 - 07:01

REGULATED INFORMATION - INSIDE INFORMATION GHENT, Belgium, 16 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that Sanofi has exercised its option to license two additional target [...]

ALK’s partner, Torii, gains paediatric approval for the house dust mite SLIT-tablet in Japan

16/02/2018 - 07:00

Copenhagen, 2018-02-16 07:00 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that its partner for Japan, Torii, has gained approval from the Japanese Ministry of Health, Labour and [...]

Amicus Therapeutics Prices Underwritten Offering of Common Stock

16/02/2018 - 01:00

CRANBURY, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced the pricing of an underwritten offering of 19,354,839 shares of its common stock at $15.50 per share. The gross [...]

IDC Announce Appointment of Auditor and Resignation of the Director

15/02/2018 - 23:46

CALGARY, Alberta, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Ima ging Dynamics Company, Ltd . ("IDC" or the "Company") (TSX Venture:IDL) is pleased to announce today that its board of directors (the “Board”) has approved a [...]

Athenex實現轉移性乳腺癌三期臨床試驗受試者招募目標，計劃在2018年第三季度進行第二次中期分析

15/02/2018 - 23:32

美國紐約州水牛城, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. ﹙Nasdaq:ATNX﹚是一間環球性的生物醫藥公司，致力於發掘、研發及商業化新型療法以治療癌症和相關病症。今日，Athenex, Inc.公布公司已實現受試者招募目標，讓公司得以在2018年第三季度對Oraxol KX-ORAX-001三期臨床試驗進行第二次中期分析。 Oraxol是一種治療癌症的創新方法， [...]

Sienna Senior Living Inc. Reports 2017 Fourth Quarter Financial Results

15/02/2018 - 23:16

MARKHAM, Ontario, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced its financial results for the year ended December 31, 2017. The Audited [...]

Xeris Pharmaceuticals Achieves Phase 3 Milestones of its Ready-to-Use Glucagon Rescue Pen for the Treatment of Severe Hypoglycemia

15/02/2018 - 23:00

Chicago, IL, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]

Xtant Medical Announces Compliance with NYSE American

15/02/2018 - 22:45

Reports Pro Forma Stockholders’ Equity of approximately $47.4M as of 2/15/18 Xtant has regained compliance with the NYSE American listing standards BELGRADE, Mont., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Xtant™ Medical [...]

Sol-Gel’s Phase 2 Data on TWIN and VERED to be Presented at the 2018 American Academy of Dermatology Annual Meeting

15/02/2018 - 22:30

NESS ZIONA, Israel, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (“Sol-Gel”) (NASDAQ: SLGL ), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and [...]

Progenics Pharmaceuticals to Present at the 2018 RBC Capital Markets Global Healthcare Conference

15/02/2018 - 22:30

NEW YORK, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, [...]

Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Wednesday, February 28, 2018

15/02/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) today announced that it will host a webcast and conference call to discuss the Company’s financial results [...]